Simpler Grants.gov #NOT-CA-25-043

NCI Forecasts Funding for Community Oncology Research Program Sites

This forecasted opportunity from the National Cancer Institute (NCI) supports the NCI Community Oncology Research Program (NCORP) Community Sites: - Government Buyer: - National Cancer Institute (NCI), part of the National Institutes of Health - OEMs and Vendors: - NCI is the primary agency and funding source - Products/Services Requested: - Participation by consortia of community hospitals and oncology practices in cancer control, prevention, treatment, and care delivery clinical trials - Annual accrual requirement of at least 70 new unique patients/participants in cancer-related trials - Optional participation in cancer care delivery studies - Unique or Notable Requirements: - Focus on engaging diverse cancer patient populations in community settings to enhance generalizability and dissemination of clinical trial results - Open to a wide range of eligible applicants, including small businesses, higher education institutions, nonprofits, and government entities - Estimated total funding of $73,000,000 with approximately 50 expected awards - Funding instrument is a cooperative agreement - No specific commercial product OEMs are mentioned; the opportunity is for research participation and clinical trial accrual, not for procurement of goods or equipment.

Description

This Notice of Funding Opportunity (NOFO) is for the National Cancer Institute (NCI) Community Oncology Research Program (NCORP) Community Sites. NCORP aims to enhance the generalizability and dissemination of clinical trial results through accrual in community settings, focusing on cancer control, prevention, treatment, and care delivery. NCORP Community Sites are consortia of community hospitals and oncology practices that accrue participants to cancer-related clinical trials and research, with specific accrual targets and optional participation in cancer care delivery studies. The program supports rigorous studies and interaction with NCORP Research Bases to provide clinical insights and input on protocol feasibility.

View original listing